SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lags Meta Settles Social Media Addiction Lawsuit with US School District in Potential Precedent for Numerous Similar Cases AI Infrastructure Spending Drives These 5 Companies Toward 10 Trillion Market Cap by 2030 AppLovin Shares Surge Amid Positive Market Sentiment Trumps Wedding Absence Highlights Presidential Focus on Iran Potential Market Implications Huaweis New Chip Design Strategy Could Intensify Competition With Nvidia and Apple HASI Q1 2026 Earnings EPS Beats Estimates by Double Digits Amid Steady Operational Performance IMDX Q1 2026 Earnings EPS beats estimates by 55 despite revenue absence OUST Q1 2026 Earnings EPS Beat Drives Positive Market Reaction Grupo Aeroportuario del Sureste SA de CV ASR Q1 2026 Earnings EPS Miss Weighs on Shares Despite Steady Traffic Trends Lantheus Q1 2026 Earnings Strong EPS Beat Driven by Radiopharmaceutical Momentum CWD Q1 2026 Earnings Major EPS Miss Highlights Operational Difficulties K Wave Media KWM Holds Steady Near Support as Trading Volume Remains Light Verisk Analytics VRSK Edges Lower Amid Consolidation Near Support Levels Mexico Fund Inc MXF Surges 175 Above Support Testing Key Resistance at 2318 Vertical Aerospace EVTL Holds Near Resistance After Modest Gains VTEX VTEX Holds Steady at 358 Amidst Consolidation Near Key Support Singapores STI Edges Up 04 Amid Cautious Sentiment Over Middle East Tensions Keppel Leads Gains JOB Q4 2025 Earnings EPS Misses Estimates Stock Edges Higher Lake Superior Acquisition Corp LKSP SPAC Stock Stays Flat Near Trust Value Awaiting Business Combination AudioCodes Ltd AUDC Surges Over 4 as Stock Approaches Key Resistance Mercury General MCY Holds Steady Near 102 After Modest Advance Bragg Gaming Group BRAG Navigates Near Support as Bearish Pressure Persists Lamb Weston LW Surges 222 as Investor Sentiment Improves Ameriprise Financial AMP Dips 37 Testing Key Support Levels Amid Market Pressure Genius Group GNS Slips 327 as Shares Test Critical Support Near 022 Akebia Therapeutics AKBA Edges Higher at 104 Key Levels in Focus